MIR29A and hepatocellular carcinoma: Using MIR16 as a normalization control as previously described [42], HCC tumor tissue (375 TCGA datasets) presented significantly lower expression levels of MIR29A than that of normal tissue (51 TCGA datasets) (p < 0.01; Figure 1A).